The Alzheimer's drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via REUTERS
Companies

New Alzheimer’s drug holds promise but adds cost pressures for Medicare

A health care worker prepares a dose of the Pfizer-BioNTech COVID-19 vaccine last week at West Philadelphia High School in Philadelphia. HANNAH BEIER / BLOOMBERG VIA GETTY IMAGES
United States

Estados Unidos podría tener la pandemia bajo control para la primavera de 2022

https://bizrepublic.com/